Investor directory
262 growth / late stage investors in biotech & life sciences
50 name Biotech & Life Sciences as a focus outright. 212 invest across industries and back it too. Between them they hold 365 contacts, 269 with an email address on file.
Counted from what each fund documents. A fund that has never stated a sector is not counted here, even though it may still invest in yours.
Some of them
Names only. Who works there and how to reach them sits behind a free account, and the first ten contacts cost nothing.
- Vulcan Capital
Seattle, US
- TVM Capital Life Science
DE · 7 contacts
- BeAble Capital
ES
- Abingworth LLP
EU · 7 contacts
- Sofinnova Partners
EU · 5 contacts
- Clarendon Fund Managers
EU · 3 contacts
Other stages
- Pre-Seed Biotech & Life Sciences investors
- Seed Biotech & Life Sciences investors
- Series A Biotech & Life Sciences investors
- Series B Biotech & Life Sciences investors
Other sectors at this stage
- Growth / Late Stage B2B SaaS investors
- Growth / Late Stage Fintech investors
- Growth / Late Stage AI & Machine Learning investors
- Growth / Late Stage Healthtech investors
- Growth / Late Stage Climate & Energy investors
- Growth / Late Stage Deeptech investors
- Growth / Late Stage Consumer investors
- Growth / Late Stage Marketplaces investors